Patents by Inventor Stephanie VERSLUYS

Stephanie VERSLUYS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRAZOLOPYRIMIDINE COMPOUNDS AS ADENOSINE RECEPTOR ANTAGONISTS
    Publication number: 20240108624
    Abstract: The invention provides a compound of formula (I), or pharmaceutically acceptable ester, amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or carbamate, wherein R1 is an optionally substituted phenyl, or an optionally substituted 5- or 6-membered aromatic heterocycle; and R2 is an optionally substituted 5- or 6-membered aromatic heterocycle. Also provided are pharmaceutical compositions comprising a compound of formula (I).
    Type: Application
    Filed: September 8, 2023
    Publication date: April 4, 2024
    Applicants: EXSCIENTIA LTD.,, EVOTEC INTERNATIONAL GMBH
    Inventors: Andrew Simon BELL, Adrian Michael SCHREYER, Stephanie VERSLUYS
  • Pyrazolopyrimidine compounds as adenosine receptor antagonists
    Patent number: 11786528
    Abstract: The invention provides a compound of formula (I), or pharmaceutically acceptable ester, amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or carbamate, wherein R1 is an optionally substituted phenyl, or an optionally substituted 5- or 6-membered aromatic heterocycle; and R2 is an optionally substituted 5- or 6-membered aromatic heterocycle. Also provided are pharmaceutical compositions comprising a compound of formula (I).
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: October 17, 2023
    Assignees: EXSCIENTIA LTD., EVOTEC INTERNATIONAL GMBH
    Inventors: Andrew Simon Bell, Adrian Michael Schreyer, Stephanie Versluys
  • PYRAZOLOPYRIMIDINE COMPOUNDS AS ADENOSINE RECEPTOR ANTAGONISTS
    Publication number: 20210251995
    Abstract: The invention provides a compound of formula (I), or pharmaceutically acceptable ester, amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or carbamate, wherein R1 is an optionally substituted phenyl, or an optionally substituted 5- or 6-membered aromatic heterocycle; and R2 is an optionally substituted 5- or 6-membered aromatic heterocycle. Also provided are pharmaceutical compositions comprising a compound of formula (I).
    Type: Application
    Filed: June 4, 2019
    Publication date: August 19, 2021
    Applicants: EXSCIENTIA LTD.,, EVOTEC INTERNATIONAL GMBH
    Inventors: Andrew Simon BELL, Adrian Michael SCHREYER, Stephanie VERSLUYS